ISRG Stock Falls -11% On A 7-day Losing Spree After Guidance Miss
Intuitive Surgical (ISRG) – a developer of minimally invasive robotic surgical systems – hit 7-day losing streak, with cumulative losses over this period amounting to a -11%. The company market cap has crashed by about $22 Bil over the last 7 days, and currently stands at $187 Bil.
The stock has YTD (year-to-date) return of 7.5% compared to 0.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity, or a trap.
What Triggered The Slide?
[1] Disappointing 2026 Procedure Growth Guidance
- PODD Tops Intuitive Surgical Stock on Price & Potential
- Is Intuitive Surgical Stock Poised For Growth?
- Pay Less, Gain More: PODD Tops Intuitive Surgical Stock
- What’s Happening With Intuitive Surgical Stock?
- Why PODD Could Outperform Intuitive Surgical Stock
- Intuitive Surgical Stock Now 16% Cheaper, Time To Buy
- Guided 13-15% Growth Below Consensus
- Stock Fell For Seven Consecutive Sessions
- Impact: Sustained Share Sell-Off, Negative Investor Sentiment
Opportunity or Trap?
Below is our take on valuation.
There is not much to fear in ISRG stock given its overall Very Strong operating performance and financial condition. Hence, despite its Very High valuation, the stock appears Attractive but Volatile (For details, see Buy or Sell ISRG).
But here is the real interesting point.
You are reading about this -11% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for ISRG stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | ISRG | S&P 500 |
|---|---|---|
| 1D | -0.7% | 1.2% |
| 7D (Current Streak) | -10.7% | -1.3% |
| 1M (21D) | -6.8% | 1.5% |
| 3M (63D) | 14.2% | 2.1% |
| YTD 2026 | -7.5% | 0.4% |
| 2025 | 8.5% | 16.4% |
| 2024 | 54.7% | 23.3% |
| 2023 | 27.1% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: ISRG Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 28 S&P constituents with 3 days or more of consecutive gains and 34 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 11 | 12 |
| 4D | 4 | 13 |
| 5D | 4 | 2 |
| 6D | 2 | 2 |
| 7D or more | 7 | 5 |
| Total >=3 D | 28 | 34 |
Key Financials for Intuitive Surgical (ISRG)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $7.1 Bil | $8.4 Bil |
| Operating Income | $1.8 Bil | $2.3 Bil |
| Net Income | $1.8 Bil | $2.3 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $2.4 Bil | $2.5 Bil |
| Operating Income | $743.4 Mil | $759.7 Mil |
| Net Income | $658.4 Mil | $704.4 Mil |
The losing streak ISRG stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.